<DOC>
	<DOCNO>NCT00465959</DOCNO>
	<brief_summary>To assess effect single dose TrIP pulmonary function patient COPD</brief_summary>
	<brief_title>Study Trospium Chloride Inhalation Powder ( TrIP ) Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Trospium chloride</mesh_term>
	<criteria>Male female COPD patient age 40 80 year Smoking history least 10 pack year Not currently use ( able wash ) long act bronchodilator Candidate wait list surgery study Using longterm oxygen therapy Hospitalization COPD exacerbation</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>COPD</keyword>
</DOC>